Octagam 5% (immune globulin intravenous [human] 5% liquid) is indicated for the treatment of primary humoral immunodeficiency such as congenital agammaglobulinemia, common variable immunodeficiency, X-linked agammaglobulinemia, Wiskott-Aldrich syndrome and severe combined immunodeficiencies. It is supplied in 1.0-, 2.5-, 5-, 10- or 25-gram single-use bottles. Octagam 5% may be stored for 24 months at +2°C to +25°C (36°F to 77°F) from the date of manufacture.
Octagam 10% (immune globulin intravenous [human] liquid preparation) is indicated for the treatment of chronic immune thrombocytopenic purpura in adults. It is supplied in 2-, 5-, 10- and 20-gram single-use bottles. Octagam 10% can be stored for 24 months at +2°C to +8°C (36°F to 46°F) from the date of manufacture. Within the first 12 months of shelf-life, the product may be stored up to nine months at ≤ +25°C (77°F); after storage at ≤ +25°C (77°F), the product must be used or discarded.
For more information about Octagam, go to biosupply.fffenterprises.com
• Bleomycin (Fresenius Kabi USA)
Bleomycin for injection is indicated to treat squamous cell carcinoma (head and neck, including mouth, tongue, tonsil, nasopharynx, oropharynx, sinus, palate, lip, buccal mucosa, gingival, epiglottis, skin, larynx; penis, cervix and vulva), lymphomas (Hodgkin's disease, non-Hodgkin's disease), testicular carcinoma (embryonal cell, choriocarcinoma and teratocarcinoma), malignant pleural effusion, as well as other conditions as determined by a physician. It is provided as a sterile lyophilized powder for reconstitution in 15- and 30-units-per-vial quantities. Bleomycin is intended for intramuscular, intravenous, subcutaneous or intrapleural administration as a palliative treatment, and has been shown to be useful as a single agent or in proven combinations with other approved chemotherapeutic agents.
For more information about Bleomycin, go to biosupply.fffenterprises.com
• Kovaltry (Bayer)
KOVALTRY, antihemophilic factor (recombinant), is a recombinant, human DNA sequence derived, full-length factor VIII concentrate indicated for use in adults and children with hemophilia A (congenital factor VIII deficiency) for: 1) on-demand treatment and control of bleeding episodes; 2) perioperative management of bleeding; and 3) routine prophylaxis to reduce the frequency of bleeding episodes. It is not indicated for the treatment of von Willebrand disease. Due to higher clearance (body-weight adjusted) in children 12 years and younger, higher or more frequent dosing may be needed. It is available as a lyophilized powder solution for intravenous injection in single-use glass vials, one vial per carton. Vial sizes include 250, 500, 1000, 2000 or 3000 IU. An administration set is provided in the package. Store at 2° to 8°C (36° to 46°F). Do not freeze.
• Idelvion (CSL Behring)
IDELVION, coagulation factor IX (recombinant), albumin fusion protein (rIX-FP), a recombinant human blood coagulation factor, is indicated for children and adults with hemophilia B (congenital factor IX deficiency) for: 1) on-demand control and prevention of bleeding episodes; 2) perioperative management of bleeding; and 3) routine prophylaxis to prevent or reduce the frequency of bleeding episodes. Idelvion is not indicated for immune tolerance induction in patients with hemophilia B. Idelvion is available as a lyophilized powder solution for intravenous injection in single-use vials. Vial sizes include 250, 500, 1000 or 2000 IU. Store at 2° to 25°C (36° to 77°F). Do not freeze.
• Eptifibatide (Teva Pharma)
EPTIFIBATIDE injection is a platelet aggregation inhibitor indicated for: 1) treatment of acute coronary syndrome managed medically or with percutaneous coronary intervention (PCI); and 2) treatment of patients undergoing PCI, including intracoronary stenting. Each vial contains 75 mg in 100 mL (0.75 mg/mL) for intravenous infusion. Store at 2° to 8°C (36° to 46°F). Do not freeze.
These products can be ordered from FFF Enterprise's BioSupply Online Ordering System or by calling Wow! Customer Care at (800) 843-7477.